These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 32852875)
1. Risk for lymph node metastasis in Epstein-Barr virus-associated gastric carcinoma with submucosal invasion. Tsuji Y; Ushiku T; Shinozaki T; Yamashita H; Seto Y; Fukayama M; Fujishiro M; Oda I; Katai H; Taniguchi H; Hasatani K; Kaizaki Y; Oga A; Nishikawa J; Akasaka R; Endo M; Sugai T; Matsumoto T; Koike K Dig Endosc; 2021 May; 33(4):592-597. PubMed ID: 32852875 [TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus status is a promising biomarker for endoscopic resection in early gastric cancer: proposal of a novel therapeutic strategy. Osumi H; Kawachi H; Yoshio T; Ida S; Yamamoto N; Horiuchi Y; Ishiyama A; Hirasawa T; Tsuchida T; Hiki N; Takeuchi K; Fujisaki J J Gastroenterol; 2019 Sep; 54(9):774-783. PubMed ID: 30826866 [TBL] [Abstract][Full Text] [Related]
3. Clinical impact of Epstein-Barr virus status on the incidence of lymph node metastasis in early gastric cancer. Osumi H; Kawachi H; Yoshio T; Fujisaki J Dig Endosc; 2020 Mar; 32(3):316-322. PubMed ID: 31762090 [TBL] [Abstract][Full Text] [Related]
4. Risk stratification for lymph node metastasis using Epstein-Barr virus status in submucosal invasive (pT1) gastric cancer without lymphovascular invasion: a multicenter observational study. Osumi H; Kawachi H; Murai K; Kusafuka K; Inoue S; Kitamura M; Yoshio T; Kakusima N; Ishihara R; Ono H; Yamamoto N; Sugino T; Nakatsuka S; Ida S; Nunobe S; Bando E; Omori T; Takeuchi K; Fujisaki J Gastric Cancer; 2019 Nov; 22(6):1176-1182. PubMed ID: 31062195 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer. Park JH; Kim EK; Kim YH; Kim JH; Bae YS; Lee YC; Cheong JH; Noh SH; Kim H Gastric Cancer; 2016 Oct; 19(4):1041-1051. PubMed ID: 26573601 [TBL] [Abstract][Full Text] [Related]
6. Very low risk of lymph node metastasis in Epstein-Barr virus-associated early gastric carcinoma with lymphoid stroma. Cheng Y; Zhou X; Xu K; Huang J; Huang Q BMC Gastroenterol; 2020 Aug; 20(1):273. PubMed ID: 32807085 [TBL] [Abstract][Full Text] [Related]
7. Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with undifferentiated early gastric cancer. Liang XQ; Wang Z; Li HT; Ma G; Yu WW; Zhou HC; Liu HB Asian J Surg; 2020 Oct; 43(10):973-977. PubMed ID: 31964584 [TBL] [Abstract][Full Text] [Related]
8. Feasibility of endoscopic treatment and predictors of lymph node metastasis in early gastric cancer. Chu YN; Yu YN; Jing X; Mao T; Chen YQ; Zhou XB; Song W; Zhao XZ; Tian ZB World J Gastroenterol; 2019 Sep; 25(35):5344-5355. PubMed ID: 31558878 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic features of early gastric carcinoma with lymphoid stroma and feasibility of endoscopic submucosal dissection. Shin DH; Kim GH; Lee BE; Lee JW; Ha DW; Jeon HK; Baek DH; Song GA; Ahn SJ; Park DY Surg Endosc; 2017 Oct; 31(10):4156-4164. PubMed ID: 28409376 [TBL] [Abstract][Full Text] [Related]
10. The Role of an Undifferentiated Component in Submucosal Invasion and Submucosal Invasion Depth After Endoscopic Submucosal Dissection for Early Gastric Cancer. Miyahara K; Hatta W; Nakagawa M; Oyama T; Kawata N; Takahashi A; Yoshifuku Y; Hoteya S; Hirano M; Esaki M; Matsuda M; Ohnita K; Shimoda R; Yoshida M; Dohi O; Takada J; Tanaka K; Yamada S; Tsuji T; Ito H; Aoyagi H; Shimosegawa T Digestion; 2018; 98(3):161-168. PubMed ID: 29870985 [TBL] [Abstract][Full Text] [Related]
11. [Predictive factors for lymph node metastasis in patients with poorly differentiated early gastric cancer]. Pang BR; Zhu ZL; Li C; Liu WT; KumarSah RD; Yan M; Zhu ZG Zhonghua Wei Chang Wai Ke Za Zhi; 2019 May; 22(5):446-450. PubMed ID: 31104430 [No Abstract] [Full Text] [Related]
12. Long-term oncological outcomes of submucosal manipulation during non-curative endoscopic submucosal dissection for submucosal invasive gastric cancer: a multicenter retrospective study in Japan. Ito H; Gotoda T; Oyama T; Kawata N; Takahashi A; Yoshifuku Y; Hoteya S; Nakagawa M; Hatta W; Hirano M; Esaki M; Matsuda M; Ohnita K; Shimoda R; Yoshida M; Dohi O; Takada J; Tanaka K; Yamada S; Tsuji T; Hayashi Y; Nakaya N; Nakamura T; Shimosegawa T Surg Endosc; 2018 Jan; 32(1):196-203. PubMed ID: 28639037 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological Characteristics and Lymph Node Metastasis Rates in Early Gastric Lymphoepithelioma-Like Carcinoma: Implications for Endoscopic Resection. Kim TS; An JY; Choi MG; Lee JH; Sohn TS; Bae JM; Min YW; Lee H; Lee JH; Rhee PL; Kim JJ; Kim KM; Min BH Gut Liver; 2024 Sep; 18(5):807-813. PubMed ID: 39054912 [TBL] [Abstract][Full Text] [Related]
14. Additional laparoscopic gastrectomy after noncurative endoscopic submucosal dissection for early gastric cancer: A single-center experience. Tian YT; Ma FH; Wang GQ; Zhang YM; Dou LZ; Xie YB; Zhong YX; Chen YT; Xu Q; Zhao DB World J Gastroenterol; 2019 Aug; 25(29):3996-4006. PubMed ID: 31413533 [TBL] [Abstract][Full Text] [Related]
15. Predictive Biomarkers of Lymph Node Metastasis in Early Gastric Cancer: A Reference of Clinicopathological Characteristics, Protein Expression, Epstein-Barr Virus Status, and Microsatellite Instability. Byeon SJ; Chang MS; Park HE; Kang D; Wang Y; Han DS; Ahn HS; Heo SC; Lee MS; Kim W; Kim SH; Ahn DW; Lee KL; Anticancer Res; 2024 Oct; 44(10):4435-4448. PubMed ID: 39348958 [TBL] [Abstract][Full Text] [Related]
16. Identifying predictors of lymph node metastasis after endoscopic resection in patients with minute submucosal cancer of the stomach. Choi JY; Park YS; Jung HY; Son DH; Ahn JY; Han S; Lim H; Choi KS; Lee JH; Kim DH; Choi KD; Song HJ; Lee GH; Kim JH Surg Endosc; 2015 Jun; 29(6):1476-83. PubMed ID: 25249150 [TBL] [Abstract][Full Text] [Related]
17. Risk factors of lymph node metastasis or lymphovascular invasion for early gastric cancer: a practical and effective predictive model based on international multicenter data. Lin JX; Wang ZK; Wang W; Desiderio J; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Li P; Parisi A; Zhou ZW; Huang CM BMC Cancer; 2019 Nov; 19(1):1048. PubMed ID: 31694573 [TBL] [Abstract][Full Text] [Related]
18. Risk factors of lymph node metastasis in 1620 early gastric carcinoma radical resections in Jiangsu Province in China: A multicenter clinicopathological study. Chen L; Wang YH; Cheng YQ; Du MZ; Shi J; Fan XS; Zhou XL; Zhang YF; Guo LC; Xu GF; He YM; Zhou D; Zou XP; Huang Q; Team TJPEGCMS J Dig Dis; 2017 Oct; 18(10):556-565. PubMed ID: 28949436 [TBL] [Abstract][Full Text] [Related]
19. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection. Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397 [TBL] [Abstract][Full Text] [Related]
20. Lymph node metastasis can be determined by just tumor depth and lymphovascular invasion in early gastric cancer patients after endoscopic submucosal dissection. Goto A; Nishikawa J; Hideura E; Ogawa R; Nagao M; Sasaki S; Kawasato R; Hashimoto S; Okamoto T; Ogihara H; Hamamoto Y; Sakaida I Eur J Gastroenterol Hepatol; 2017 Dec; 29(12):1346-1350. PubMed ID: 29084076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]